FindTrial
Sign In

Study on the relationship between a new bioactive peptide hormone Spexin and glycolipid metabolism and its predictive value in gestational diabetes mellitus

Study on the relationship between a new bioactive peptide hormone Spexin and glycolipid metabolism and its predictive value in gestational diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091590
Enrollment
Unknown
Registered
2024-10-30
Start date
2021-06-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus

Interventions

GDM group:NA
Normal pregnant women group:NA

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: a. Meet the diagnostic criteria of GDM; b. Single pregnancy; c. No previous treatment for diabetes, including diet, exercise and drug therapy; d. Archival information is kept intact.

Exclusion criteria

Exclusion criteria: a. Patients with diseases related to important organs; b. Patients with other complications during pregnancy; c. Patients with a history of diabetes before pregnancy; d. Recent history of taking glucocorticoids and other drugs; e. Patients with thyroid disease; f. Patients with retinal, kidney, cardiovascular and cerebrovascular diseases and peripheral vascular diseases (including those with corresponding clinical manifestations).

Design outcomes

Primary

MeasureTime frame
Blood glucose;Spexin;Glycosylated hemoglobin;lipid level;insulin;Sex hormone binding protein;—

Countries

China

Contacts

Public ContactLu Yan

The First Affiliated Hospital of Soochow University

lucia1817@163.com+86 139 6215 8315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026